NSC |
Compound |
Enrichment |
Correlation |
NSC 339638 |
2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt |
0.046717891610184 |
0.39694789 |
NSC 348121 |
4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- |
0.046717891610184 |
0.29621096 |
NSC 352741 |
Null |
0.046717891610184 |
0.38509481 |
NSC 625154 |
21-Oxabicyclo[16.2.1]heneicosane-4,9,14,18,20-pentaene, 3,6,8,11,13,16-hexaoxo-2,2,7,7,,12,12,17,17-octamethyl- |
0.0467178916101845 |
0.64256367 |
NSC 632620 |
9-Methoxy-2-[(benzoyloxy)methyl]-5,11-dimethyl- 6H-pyrido[4,3-b]carbazolium iodide |
0.0467178916101845 |
0.41505872 |
NSC 639662 |
Miltirone |
0.0467178916101845 |
0.63303214 |
NSC 641297 |
ANTINEOPLASTIC-641297 |
0.0467178916101845 |
0.21645601 |
NSC 645159 |
Null |
0.0467178916101845 |
0.67750997 |
NSC 646610 |
Null |
0.0467178916101845 |
0.34015098 |
NSC 653624 |
Null |
0.0467178916101845 |
0.4046776 |